Metabolomic analysis of breath volatile organic compounds reveals unique breathprints in children with inflammatory bowel disease: A pilot study

Alimentary Pharmacology and Therapeutics

Volumn 40, Issue 5, 2014, Pages 498-507

  Patel, N ^a   Alkhouri, N ^a   Eng, K ^a   Cikach, F ^b   Mahajan, L ^a   Yan, C ^a   Grove, D ^b   Rome, E S ^b   Lopez, R ^b   Dweik, R A ^b,c  

^a Department of Pediatric Gastroenterology Mailcode:A111 ^*  (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c Respiratory Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALKENES; BIOLOGICAL MARKERS; BREATH TESTS; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; GASTROINTESTINAL TRACT; HUMANS; MASS SPECTROMETRY; METABOLOMICS; PILOT PROJECTS; VOLATILE ORGANIC COMPOUNDS; YOUNG ADULT;

EID: 84905747379     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12861     Document Type: Article

References (27)

1. Loftus EV Jr,. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504-17.
2. Vermeire S, Van Assche G, Rutgeerts P,. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 2006; 55: 426-31.
3. Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ,. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol 2008; 103: 162-9.
4. van Rheenen PF, Van de Vijver E, Fidler V,. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ 2010; 341: c3369.
5. Phillips M, Herrera J, Krishnan S, Zain M, Greenberg J, Cataneo RN,. Variation in volatile organic compounds in the breath of normal humans. J Chromatogr B Biomed Sci Appl 1999; 729: 75-88.
6. Hunter GW, Dweik RA,. Applied breath analysis: an overview of the challenges and opportunities in developing and testing sensor technology for human health monitoring in aerospace and clinical applications. J Breath Res 2008; 2: 037020.
7. Mashir A, Dweik RA,. Exhaled breath analysis: the new interface between medicine and engineering. Adv Powder Technol 2009 Sep; 20: 420-5.
8. Braun P, Gmachl C, Dweik R,. Bridging the collaborative gap: realizing the clinical potential of breath analysis for disease diagnosis and monitoring- tutorial. Sensors J IEEE 2012; 11: 3258-70.
9. Paschke KM, Mashir A, Dweik RA,. Clinical applications of breath testing. F1000 Med Rep 2010; 2: 56.
10. Dweik RA,. The great challenge for exhaled breath analysis: embracing complexity, delivering simplicity. J Breath Res 2011; 5: 030201.
11. Hyams JS, Ferry GD, Mandel FS, et al,. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991; 12: 439-47.
12. Turner D, Otley AR, Mack D, et al,. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology 2007; 133: 423-32.
13. Levine A, Griffiths A, Markowitz J, et al,. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011; 17: 1314-21.
14. Samara MA, Tang WH, Cikach F Jr, et al,. Single exhaled breath metabolomic analysis identifies unique breathprint in patients with acute decompensated heart failure. J Am Coll Cardiol 2013; 61: 1463-4.
15. Kumar S, Huang J, Abbassi-Ghadi N, Spanel P, Smith D, Hanna GB,. Selected ion flow tube mass spectrometry analysis of exhaled breath for volatile organic compound profiling of esophago-gastric cancer. Anal Chem 2013; 85: 6121-8.
16. Prince BJ, Milligan DB, McEwan MJ,. Application of selected ion flow tube mass spectrometry to real-time atmospheric monitoring. Rapid Commun Mass Spectrom 2010; 24: 1763-9.
17. Smith D, Spanel P,. Selected ion flow tube mass spectrometry (SIFT-MS) for on-line trace gas analysis. Mass Spectrom Rev 2005; 24: 661-700.
18. Risby TH, Sehnert SS,. Clinical application of breath biomarkers of oxidative stress status. Free Radic Biol Med 1999; 27: 1182-92.
19. Arasaradnam RP, Covington JA, Harmston C, Nwokolo CU,. Review article: next generation diagnostic modalities in gastroenterology-gas phase volatile compound biomarker detection. Aliment Pharmacol Ther 2014; 39: 780-9.
20. Arasaradnam RP, Ouaret N, Thomas MG, et al,. A novel tool for noninvasive diagnosis and tracking of patients with inflammatory bowel disease. Inflamm Bowel Dis 2013; 19: 999-1003.
21. Ross BM,. Sub-parts per billion detection of trace volatile chemicals in human breath using selected ion flow tube mass spectrometry. BMC Res Notes 2008; 1: 41.
22. Smith D, Spanel P, Herbig J, Beauchamp J,. Mass spectrometry for real-time quantitative breath analysis. J Breath Res 2014; 8: 027101.
23. Walton C, Fowler DP, Turner C, et al,. Analysis of volatile organic compounds of bacterial origin in chronic gastrointestinal diseases. Inflamm Bowel Dis 2013; 19: 2069-78.
24. Dryahina K, Spanel P, Pospisilova V, et al,. Quantification of pentane in exhaled breath, a potential biomarker of bowel disease, using selected ion flow tube mass spectrometry. Rapid Commun Mass Spectrom 2013; 27: 1983-92.
25. Kokoszka J, Nelson RL, Swedler WI, Skosey J, Abcarian H,. Determination of inflammatory bowel disease activity by breath pentane analysis. Dis Colon Rectum 1993; 36: 597-601.
26. Gevers D, Kugathasan S, Denson LA, et al,. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 2014; 15: 382-92.
27. Morita H, Nakanishi K, Dohi T, Yasugi E, Oshima M,. Phospholipid turnover in the inflamed intestinal mucosa: arachidonic acid-rich phosphatidyl/ plasmenyl-ethanolamine in the mucosa in inflammatory bowel disease. J Gastroenterol 1999; 34: 46-53.